If the Recipient creates an invention containing the Software ('Recipient Invention') and wishes to patent the Recipient Invention, Recipient agrees to notify the Provider of the Recipient Invention prior to seeking patent protection and to work in good faith with the Provider to determine the inventive contributions of the Recipient and Provider. Neither Provider nor Recipient promise rights in advance for inventions developed under this Agreement. The Provider and Recipient each shall retain, subject to applicable laws, title to any patent, copyright, trademark, or other intellectual property of their respective employees developed or created using the Software.

Recipient agrees that any of its publications or presentations utilizing this Software will include appropriate acknowledgement of Provider's contribution of the Software.

Provider reserves the right to distribute Software to others and to use it for Provider's own purposes. It is understood that nothing herein shall be deemed to constitute, by implication or otherwise, the grant to either Party by the other of any license or other rights under any patent, patent application or other intellectual property right or interest.

If Recipient desires to sell its own commercial software that incorporates the Software or use Software for commercial purposes or applications (including consulting), Recipient will contact the NCI Technology Transfer Center (attention: Technology Transfer Manager for the NCI Division of Cancer Control and Population Sciences) at Title in the Software shall remain with the Provider.

The Recipient agrees to not use the Software for diagnostic purposes in human subjects. Software will not be used by Recipient as an agent, device, or instrument of treatment or intervention in research with human subjects where such use would require the approval of an Institutional Review Board. Recipient agrees to comply with all Federal regulations applicable to research projects and handling of research materials.

The Recipient agrees to not attempt to reverse engineer the Software.

The Provider and Recipient agree as follows:

'Software': Match*Pro, a tool developed by IMS, Inc.

'Recipient': the party who receives software materials from the Provider under this agreement.

'Provider': the National Cancer Institute.

Please review the following terms carefully: Match*Pro application is used to conduct probabilistic record linkages. Thank you for your interest in the Match*Pro Software. Terms of Use Agreement for the Match*Pro Software

Seer pro